Ukraine to Introduce New Prescription-Drug Monitoring System
On July 4, 2013, the State Administration of Ukraine on Medicinal Products held a public test of a new prescription drug monitoring system aimed at preventing counterfeit medicines from entering the supply chain.
The implementation of this system has been made possible by coating each drug package with a unique two-dimensional GS1 DataMatrix barcode. The GS1 system has been tested in the European Union and recommended for use by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Ukraine and the EU are planning to gradually implement the new drug monitoring system in Ukraine by 2017.
In 2011, the EU published the Directive No. 2011/62/EU (“the Falsified Medicines Directive”) according to which drug manufacturers throughout the EU need to mark all registered medical products with a unique identifier. The Directive came into force in January 2013.
Prepared by: Maya Kryvoshei
For more information, please contact email@example.com.
Source: State Administration of Ukraine on Medicinal Products
August 2013 News
- Croatia Amends Patent Legislation
- New Laws on Medicines and Medical Devices Enter into force in Croatia
- Croatia Amends Customs Regulations
- Amendments to Hungarian Patent Law Explained
- Poland and China Launch Patent Prosecution Highway Program
- New GI Law Enters into Force in Kosovo
- Georgia PTO Publishes Special IP Gazette with Geographical Indications
- Ukraine to Introduce New Prescription-Drug Monitoring System
- Romanian Customs Seize EUR 2M Worth of Counterfeits
- Serbian Customs Seize Counterfeit Apparel, Anti-Impotence Drugs
- Bulgaria Customs Seize Fake Perfumes, Belts, Sweaters